NEW YORK (GenomeWeb News) – Life sciences marketing company Genycell will distribute and sell ImaGenes' clone collection in Spain and Portugal, ImaGenes said today.

Granada, Spain-based Genycell will market ImaGenes clone collections, which includes open reading frame clones from Invitrogen and Genecopoeia, as well as the ORFeome Collection, which is a National Institutes of Health-led initiative to provide most human ORFs as a source of sequence-validated cDNA, ImaGenes said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Hundreds of scientists have signed a letter criticizing the open-access Plan S, ScienceInsider reports.

NPR speaks with Rep. Eddie Bernice Johnson (D-Texas) about the US House of Representatives science committee.

A start-up company aiming to match cancer patients to treatments closes after about six weeks, Stat News reports.

In PLOS this week: somatic mutation associations unearthed in thousands of cancer exomes, pathogen detection assay, and more.